DPP-IV Inhibitors

Features DPP-IV Inhibitors

Type 2 Diabetes is a progressive disease that occurs as a result of metabolic dysfunction.
Gastrointestinal hormones produced as a result of nutrient ingestion contribute to the secretion of insulin.
They not only enhance the secretion of insulin, but also play a vital role in the neogenesis and proliferation of Pancreatic beta cells and the inhibition of glucagons.This presentation is a visual account of Type 2 Diabetes and the beneficial use of DPP-IV inhibitors in taking control of the body’s natural metabolism.